SCHEMBL22067828

SCHEMBL22067828

Clc1cc2cc(c1)n(-c1ccccc1)c1ccccc1n(-c1ccccc1)c1cc(Cl)cc(c1)s2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 2/20 0.36
MAT2A P31153 2/20 0.35
ADORA2B P29275 4/20 0.35
ALDH1A1 P00352 3/20 0.34
GAA P10253 2/20 0.34
HTT P42858 2/20 0.34
MAPT P10636 1/20 0.34
OPRD1 P41143 1/20 0.34
OPRK1 P41145 1/20 0.34
PAX8 Q06710 1/20 0.34
TLR9 Q9NR96 1/20 0.34
ADORA1 P30542 2/20 0.33
TSHR P16473 1/20 0.33
GSK3A P49840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22067823 0.78 L3MBTL1 (0.56) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL22068226 0.76 HSD17B10 (0.41) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL24845796 0.65 L3MBTL1 (0.46) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL10014872 0.65 ATM (0.64) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL29945006 0.61 L3MBTL1 (0.57) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL22067871 0.60 ATM (0.50) HSD17B10L3MBTL1ATMKDM4EMEN1
SCHEMBL28569692 0.60 L3MBTL1 (0.55) L3MBTL1ATMKDM4EMEN1KMT2A
SCHEMBL18627656 0.60 L3MBTL1 (0.67) L3MBTL1ATMKDM4EMEN1KMT2A
SCHEMBL11899480 0.60 L3MBTL1 (0.67) L3MBTL1ATMKDM4EMEN1KMT2A
SCHEMBL11557771 0.60 ALDH1A1 (0.55) HSD17B10L3MBTL1ATMKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11335862-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-17 US disclosed
US-20200185606-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11335862-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device PIEZO1, KCNC1, L1CAM HSD17B10 2758/4885L3MBTL1 1302/4885ATM 3529/4885
US-20200185606-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, KCNC1, L1CAM HSD17B10 2758/4885L3MBTL1 1302/4885ATM 3529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.